Joel Greenblatt’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Joel Greenblatt's ARQT Position: Q3 2026 in Review
Joel Greenblatt reduced its Arcutis Biotherapeutics (ARQT) stake by 0.9% in Q3 2026, selling an estimated $4.47K and leaving 18,861 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.
Joel Greenblatt first reported a position in ARQT in Q2 2026 and has held it in 2 quarters since. The position peaked at $499K in Q2 2026. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Joel Greenblatt held 18,861 shares of Arcutis Biotherapeutics worth $498K as of Q3 2026.
- Joel Greenblatt sold 171 Arcutis Biotherapeutics shares in Q3 2026, an estimated $4.47K.
- Arcutis Biotherapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1586 holding.
- Joel Greenblatt first reported a position in Arcutis Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
- Joel Greenblatt's Arcutis Biotherapeutics position peaked at $499K in Q2 2026.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.